AllianceBernstein’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15M Sell
273,505
-45,474
-14% -$2.5M ﹤0.01% 1012
2025
Q1
$22.5M Buy
318,979
+61,594
+24% +$4.35M 0.01% 843
2024
Q4
$16.9M Sell
257,385
-22,055
-8% -$1.45M 0.01% 964
2024
Q3
$19.6M Sell
279,440
-15,204
-5% -$1.07M 0.01% 921
2024
Q2
$24.3M Buy
294,644
+203,137
+222% +$16.7M 0.01% 820
2024
Q1
$7.99M Buy
91,507
+1,024
+1% +$89.4K ﹤0.01% 1270
2023
Q4
$8.72M Buy
90,483
+1,762
+2% +$170K ﹤0.01% 1228
2023
Q3
$7.85M Sell
88,721
-64,613
-42% -$5.72M ﹤0.01% 1204
2023
Q2
$13.3M Sell
153,334
-23,357
-13% -$2.02M 0.01% 1000
2023
Q1
$17.2M Buy
176,691
+88,833
+101% +$8.64M 0.01% 892
2022
Q4
$9.09M Sell
87,858
-4,309
-5% -$446K ﹤0.01% 1142
2022
Q3
$7.81M Sell
92,167
-137,670
-60% -$11.7M ﹤0.01% 1194
2022
Q2
$19M Buy
229,837
+48,476
+27% +$4.02M 0.01% 874
2022
Q1
$14M Sell
181,361
-191,716
-51% -$14.8M 0.01% 1056
2021
Q4
$33M Buy
373,077
+35,043
+10% +$3.1M 0.01% 758
2021
Q3
$26.1M Buy
338,034
+184,974
+121% +$14.3M 0.01% 838
2021
Q2
$12.8M Buy
153,060
+46,174
+43% +$3.85M 0.01% 1109
2021
Q1
$8.07M Sell
106,886
-311,202
-74% -$23.5M ﹤0.01% 1300
2020
Q4
$36.7M Buy
418,088
+117,161
+39% +$10.3M 0.02% 670
2020
Q3
$22.9M Buy
300,927
+49,403
+20% +$3.76M 0.01% 759
2020
Q2
$31M Buy
251,524
+150,092
+148% +$18.5M 0.02% 638
2020
Q1
$8.57M Sell
101,432
-6,290
-6% -$532K 0.01% 960
2019
Q4
$9.11M Buy
107,722
+1,874
+2% +$158K 0.01% 1122
2019
Q3
$7.13M Sell
105,848
-1,121
-1% -$75.6K ﹤0.01% 1181
2019
Q2
$9.16M Buy
106,969
+1,032
+1% +$88.4K 0.01% 1095
2019
Q1
$9.41M Sell
105,937
-813
-0.8% -$72.2K 0.01% 1076
2018
Q4
$9.09M Sell
106,750
-2,072
-2% -$176K 0.01% 1025
2018
Q3
$10.6M Buy
108,822
+454
+0.4% +$44K 0.01% 951
2018
Q2
$10.2M Sell
108,368
-88,832
-45% -$8.37M 0.01% 954
2018
Q1
$16M Buy
197,200
+48,820
+33% +$3.96M 0.01% 827
2017
Q4
$13.2M Buy
148,380
+31,320
+27% +$2.79M 0.01% 878
2017
Q3
$10.9M Buy
117,060
+684
+0.6% +$63.7K 0.01% 915
2017
Q2
$10.6M Buy
116,376
+2,756
+2% +$250K 0.01% 907
2017
Q1
$9.97M Sell
113,620
-29
-0% -$2.55K 0.01% 926
2016
Q4
$9.42M Buy
113,649
+3,047
+3% +$252K 0.01% 922
2016
Q3
$10.2M Buy
110,602
+1,250
+1% +$116K 0.01% 885
2016
Q2
$8.51M Buy
109,352
+1,300
+1% +$101K 0.01% 905
2016
Q1
$8.91M Sell
108,052
-3,702
-3% -$305K 0.01% 879
2015
Q4
$11.7M Sell
111,754
-317
-0.3% -$33.2K 0.01% 826
2015
Q3
$11.8M Sell
112,071
-921
-0.8% -$97K 0.01% 828
2015
Q2
$15.5M Buy
112,992
+4,685
+4% +$641K 0.01% 798
2015
Q1
$13.5M Buy
108,307
+2,377
+2% +$296K 0.01% 831
2014
Q4
$9.58M Sell
105,930
-573
-0.5% -$51.8K 0.01% 895
2014
Q3
$7.69M Buy
106,503
+903
+0.9% +$65.2K 0.01% 937
2014
Q2
$6.57M Buy
105,600
+1,548
+1% +$96.3K 0.01% 1004
2014
Q1
$7.1M Sell
104,052
-580,891
-85% -$39.6M 0.01% 964
2013
Q4
$48.1M Sell
684,943
-110,404
-14% -$7.76M 0.04% 448
2013
Q3
$57.4M Buy
795,347
+53,367
+7% +$3.85M 0.06% 384
2013
Q2
$41.4M Buy
+741,980
New +$41.4M 0.04% 444